Diagnosis of Filarial Infections
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Investigations of Filarial Nematode Motility, Response to Drug Treatment, and Pathology
Western Michigan University ScholarWorks at WMU Dissertations Graduate College 8-2015 Investigations of Filarial Nematode Motility, Response to Drug Treatment, and Pathology Charles Nutting Western Michigan University, [email protected] Follow this and additional works at: https://scholarworks.wmich.edu/dissertations Part of the Biochemistry Commons, Biology Commons, and the Pathogenic Microbiology Commons Recommended Citation Nutting, Charles, "Investigations of Filarial Nematode Motility, Response to Drug Treatment, and Pathology" (2015). Dissertations. 745. https://scholarworks.wmich.edu/dissertations/745 This Dissertation-Open Access is brought to you for free and open access by the Graduate College at ScholarWorks at WMU. It has been accepted for inclusion in Dissertations by an authorized administrator of ScholarWorks at WMU. For more information, please contact [email protected]. INVESTIGATIONS OF FILARIAL NEMATODE MOTILITY, RESPONSE TO DRUG TREATMENT, AND PATHOLOGY by Charles S. Nutting A dissertation submitted to the Graduate College in partial fulfillment of the requirements for the degree of Doctor of Philosophy Biological Sciences Western Michigan University August 2015 Doctoral Committee: Rob Eversole, Ph.D., Chair Charles Mackenzie, Ph.D. Pamela Hoppe, Ph.D. Charles Ide, Ph.D. INVESTIGATIONS OF FILARIAL NEMATODE MOTILITY, RESPONSE TO DRUG TREATMENT, AND PATHOLOGY Charles S. Nutting, Ph.D. Western Michigan University, 2015 More than a billion people live at risk of chronic diseases caused by parasitic filarial nematodes. These diseases: lymphatic filariasis, onchocerciasis, and loaisis cause significant morbidity, degrading the health, quality of life, and economic productivity of those who suffer from them. Though treatable, there is no cure to rid those infected of adult parasites. The parasites can modulate the immune system and live for 10-15 years. -
Detection of the Filarial Parasite Mansonella Streptocerca in Skin Biopsies by a Nested Polymerase Chain Reaction-Based Assay Peter U
Smith ScholarWorks Biological Sciences: Faculty Publications Biological Sciences 1998 Detection of the Filarial Parasite Mansonella streptocerca in Skin Biopsies by a Nested Polymerase Chain Reaction-Based Assay Peter U. Fischer Dietrich W. Büttner Jotham Bamuhiiga Steven A. Williams Smith College, [email protected] Follow this and additional works at: https://scholarworks.smith.edu/bio_facpubs Part of the Biology Commons Recommended Citation Fischer, Peter U.; Büttner, Dietrich W.; Bamuhiiga, Jotham; and Williams, Steven A., "Detection of the Filarial Parasite Mansonella streptocerca in Skin Biopsies by a Nested Polymerase Chain Reaction-Based Assay" (1998). Biological Sciences: Faculty Publications, Smith College, Northampton, MA. https://scholarworks.smith.edu/bio_facpubs/41 This Article has been accepted for inclusion in Biological Sciences: Faculty Publications by an authorized administrator of Smith ScholarWorks. For more information, please contact [email protected] Am. J. Trop. Med. Hyg., 58(6), 1998, pp. 816±820 Copyright q 1998 by The American Society of Tropical Medicine and Hygiene DETECTION OF THE FILARIAL PARASITE MANSONELLA STREPTOCERCA IN SKIN BIOPSIES BY A NESTED POLYMERASE CHAIN REACTION±BASED ASSAY PETER FISCHER, DIETRICH W. BUÈ TTNER, JOTHAM BAMUHIIGA, AND STEVEN A. WILLIAMS Clark Science Center, Department of Biological Sciences, Smith College, Northampton, Massachusetts; Department of Helminthology and Entomology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Agency for Technical Cooperation and Basic Health Services, Fort Portal, Uganda Abstract. To differentiate the skin-dwelling ®lariae Mansonella streptocerca and Onchocerca volvulus, a nested polymerase chain reaction (PCR) assay was developed from small amounts of parasite material present in skin biopsies. One nonspeci®c and one speci®c pair of primers were used to amplify the 5S rDNA spacer region of M. -
S6 Ivermectin.Pdf
21st WHO Expert Committee on the Selection and Use of Essential Medicines: Application for inclusion of ivermectin on the WHO Model List of Essential Medicines (EML) and Model List of Essential Medicines for Children (EMLc) Submitted: December 2016 Submitted by: Dr. Antonio Montresor Department of Control of Neglected Tropical Diseases Preventive Chemotherapy and Transmission Control World Health Organization Geneva, Switzerland Application for inclusion of ivermectin on the WHO Model List of Essential Medicines (EML) and Model List of Essential Medicines for Children (EMLc) Contents General items ...................................................................................................................... 4 1. Summary statement of the proposal for inclusion, change or deletion ........................... 4 2. Name of the WHO technical department and focal point supporting the application .... 5 3. Name of organization consulted and/or supporting the application ............................... 5 4. International Nonproprietary Name (INN) and anatomical therapeutic chemical (ATC) code of the medicine ................................................................................................................. 6 5. Formulation(s) and strength(s) proposed for inclusion; including adult and paediatric .. 6 5.1 Strongyloidiasis ....................................................................................................................... 6 5.2 Soil-transmitted helminthiasis ............................................................................................... -
Onchocerciasis
ONCHOCERCIASIS GUIDELINES FOR STOPPING MASS DRUG ADMINISTRATION AND VERIFYING ELIMINATION OF HUMAN ONCHOCERCIASIS CRITERIA AND PROCEDURES ANNEXES − Annex 1. Key questions Key question 1 Which test (and at which threshold and time-point) can be used to demonstrate interruption of transmission of onchocerciasis (and therefore stop ivermectin administration)? Test Threshold Time point O-150 PCR in black flies (head) < 1/1000 (0.1%) parous Peak transmission flies or < 1/2000 (0.05%) in season all flies assuming a 50% parous rate. A 95% CI will be used. PCR in black flies (body) Optional, but protocol calls Peak transmission for switching to testing season heads at first positive pool Ov-16 serology in children (< 5 y) < 0.1% (CI: 95%); has been operationalized in children < 10 y Ov-16 serology in children (< 10 y) < 0.1%. A 95% CI will be In same quarter of used. year as flies are collected Annual biting rate NA (taken into account in Poolscreen) Annual transmission potential < 20. A 95% CI will be used Calculated from flies collected during peak transmission season as above for PCR Skin snips (microscopic evaluation) NA Skin snips (PCR) Only done on those As soon as possible children who test OV-16 after serological positive results are known DEC test (patch) NA DEC test (oral, Mazzotti test) NA Ultrasonography NA Antigen testing (dipstick for urine or tears) NA CI, confidence interval; NA, not applicable; Ov-16, IgG4 antibodies against Onchocerca volvulus 16 antigen; PCR, polymerase chain reaction; y, years 1 − Key question 2 Which test (and at which threshold and time-point) can be used to demonstrate elimination of onchocerciasis? Test Threshold Time point O-150 PCR in black flies (head) < 1/1000 (0.1%) parous Peak transmission flies or < 1/2000 (0.05%) in season 3 years after all flies assuming a 50% cessation of MDA parous rate. -
Epidemiology of Mansonella Perstans in the Middle Belt of Ghana
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Debrah et al. Parasites & Vectors (2017) 10:15 DOI 10.1186/s13071-016-1960-0 RESEARCH Open Access Epidemiology of Mansonella perstans in the middle belt of Ghana Linda Batsa Debrah1,7*, Norman Nausch2, Vera Serwaa Opoku1, Wellington Owusu1, Yusif Mubarik1, Daniel Antwi Berko1, Samuel Wanji6, Laura E. Layland3, Achim Hoerauf3, Marc Jacobsen2, Alexander Yaw Debrah4 and Richard O. Phillips5 Abstract Background: Mansonellosis was first reported in Ghana by Awadzi in the 1990s. Co-infections of Mansonella perstans have also been reported in a small cohort of patients with Buruli ulcer and their contacts. However, no study has assessed the exact prevalence of the disease in a larger study population. This study therefore aimed to find out the prevalence of M. perstans infection in some districts in Ghana and to determine the diversity of Culicoides that could be potential vectors for transmission. Methods: From each participant screened in the Asante Akim North (Ashanti Region), Sene West and Atebubu Amantin (Brong Ahafo Region) districts, a total of 70 μl of finger prick blood was collected for assessment of M. perstans microfilariae. Centre for Disease Control (CDC) light traps as well as the Human Landing Catch (HLC) method were used to assess the species diversity of Culicoides present in the study communities. Results: From 2,247 participants, an overall prevalence of 32% was recorded although up to 75% prevalence was demonstrated in some of the communities. Culicoides inornatipennis was the only species of Culicoides caught with the HLC method. -
The Medical Letter
Page 1 of 2 FILARIASIS1 Drug Adult dosage Pediatric dosage Wuchereria bancrofti, Brugia malayi, Brugia timori Drug of choice:2 Diethylcarbamazine* 6 mg/kg/d PO in 3 doses x 6 mg/kg/d PO in 3 doses x 12d3,4 12d3,4 Loa loa Drug of choice:5 Diethylcarbamazine* 6 mg/kg/d PO in 3 doses x 6 mg/kg/d PO in 3 doses x 12d3,4 12d3,4 Mansonella ozzardi Drug of choice: See footnote 6 Mansonella perstans Drug of choice: Albendazole7, 8 400 mg PO bid x 10d 400 mg PO bid x 10d OR Mebendazole7 100 mg PO bid x 30d 100 mg PO bid x 30d Mansonella streptocerca Drug of choice:9 Diethylcarbamazine* 6 mg/kg/d PO x 12d4 6 mg/kg/d PO x 12d4 OR Ivermectin7, 1 0 150 mcg/kg PO once 150 mcg/kg PO once Tropical Pulmonary Eosinophilia (TPE)11 Drug of choice: Diethylcarbamazine* 6 mg/kg/d in 3 doses x 12-21d4 6 mg/kg/d in 3 doses x 12-21d4 Onchocerca volvulus (River blindness) Drug of choice: Ivermectin10,12 150 mcg/kg PO once, repeated 150 mcg/kg PO once, repeated every 6-12 mos until every 6-12mos until asymptomatic asymptomatic * Availability problems. See table below. 1. Antihistamines or corticosteroids may be required to decrease allergic reactions to components of disintegrating microfilariae that result from treatment, especially in infection caused by Loa loa. Endosymbiotic Wolbachia bacteria may have a role in filarial devel- opment and host response, and may represent a potential target for therapy. -
Prevalence of Loa Loa and Mansonella Perstans Detection in Urban Areas of Southeast Gabon
Vol. 12(2), pp. 44-51, July-December 2020 DOI: 10.5897/JPVB2020.0390 Article Number: 29A046465474 ISSN: 2141-2510 Copyright ©2020 Journal of Parasitology and Author(s) retain the copyright of this article http://www.academicjournals.org/JPVB Vector Biology Full Length Research Paper Prevalence of Loa loa and Mansonella perstans detection in urban areas of Southeast Gabon Eyang-Assengone Elsa Rush1, Roland Dieki2, Mvoula Odile Ngounga3, Antoine Roger Mbou Moutsimbi2, Jean Bernard Lekana-Douki2 and Jean Paul Akue2* 1Department of Tropical Infectiology, Ecole Doctorale Régionaled‟ Afrique Centrale, Franceville, Gabon. 2Department of Parasitology, Interdisciplinary Center for Medical Research of Franceville, Franceville, Gabon. 3Department of Health, Ministry of National Defense, Gabon. Received 19 May 2020 Accepted 20 October 2020 Loa loa and Mansonella perstans are two filarial species commonly found in Gabon loiasis has gained attention because of severe adverse events occurring in individuals harboring very high L. loa microfilarial loads after treatment with ivermectin. However, most studies were carried out in rural areas. This work aimed at the study of the prevalence of filarial infections in different urban areas of southeast Gabon. The cross-sectional survey was conducted between May and December 2018 in Franceville, Moanda, and Mvengue. Participants provided written informed consent, a questionnaire to collect data on demographics and related clinical signs (ocular passage of the worm, Calabar swelling, and pruritus). Blood was collected to search for filarial infections. Plasma and blood pellets were separated after centrifugation. The plasma was used for detection of specific IgG4 by ELISA. In total, 545 were samples collected, the overall prevalence of filarial infection in the three cities was 4.77% (95% CI: 3.06–7.97). -
Parasitology. Filarial Worms
Parasitology. Filarial worms - the hair like nematodes. Characteristics. All use intermediate hosts - arthropods of some kind. Mites, blackflies, mosquitoes. Many species have endo-symbionts - Wolbachia as essential endosymbionts. The nematodes cannot live without the bacterial endosymbionts. Order Filariata - adults live in tissues of vertebrate host. F. Onchocercidae Many genera that occur in vertebrates (no fish yet). -cosmopolitan- Species of human health importance. Wuchereria bancrofti, Loa loa, Brugia malayi, Onchocerca volvulus Wuchereria bancrofti -Bancroftian filariasis - also causes elephantiasis Distribution: Africa, Asia, Pacific Islands, South America -originally in Africa, probably disseminated with people from Africa world-wide. Adults Males 40 mm, females 6 - 10 cm. See life cycle (usually we call the developing nematans Juveniles instead of Larvae). Lymphatic system - adults - cause blockages - thus, the lymph system builds up long term causing connective tissue to increase due to permanent edema. *microfilariae are released into the lymph system by ovoviparous females. Enter blood via lymphatic thoracic duct to blood stream. *microfilariae cycle deep in blood in daytime, and emerge into periph. circulation during night time. Adapted to mosquitoe host. 3rd stage juveniles are infective and stay in proboscis of mosquito. *Vectors - Anopheles, Mansonia, and some others. - see life cycle. See book for control measures. Best way is mosquito control. *Treatment - Diethyl Carbamazide - laced table salt. Surgery for disfigurment. (Brugia malayi) - good lab model that is easily maintained in rodents. Onchocerca volvulus Human parasite - no known reserviors. *Intermediate host necessary - Blackflies of the genus Simulium (F. Simuliidae) - the larvae of simluiids live in fast flowing streams, they are shredders, and eat organic material and attach to the substrate with silken threads. -
Nematodes from Tissues
Nematodes from tissues Filariae, Toxocara spp., Trichinella spiralis Filariae Mansonella perstans D, N, B Mansonella ozzardi D, N, B Mansonella streptocerca SB Loa loa: œdème fugace de Calabar, eye D, B Onchocerca volvulus: river blindness SB Wuchereria bancrofti, Brugia malayi: lymphatic filariae, elephantiasis N, B D: day – N: night – B: blood – SB: skin biopsy Filariae Mansonella perstans Africa, South America, Surinam Mansonella ozzardi South America Mansonella streptocerca West Africa Loa loa West and Central Africa Onchocerca volvulus Africa, South America Wuchereria bancrofti Africa, South America, Asia Brugia malayi Asia Microfilariae that can be seen in peripheral blood in Congo-Kinshasa, according to J. Sonnet and J. Vandepitte. Mansonella perstans Loa loa Wuchereria bancrofti Periodicity day/night day night Vector flies flies mosquitoes (Culicoides spp.) (Chrysops spp.) (Culex, Anopheles, …) Size < 200 µm > 250 (230) µm > 250 µm Tail terminal nuclei terminal nuclei no terminal nuclei Sheath no yes (not stained by yes (slightly stained by Giemsa) Giemsa) Mansonella perstans Small microfilaria whitout a sheath (approximately 200 x 4 to 5 µm) with a blunt tail filled with nuclei (Thin film stained with Giemsa). Mansonella perstans and Loa loa Loa loa is distinctly longer and thicker than M. perstans. In the thick film the microfilaria of Loa loa show irregular coiling. The sheath does not stain with Giemsa (Thick film stained with Giemsa). Courtesy CDC Mansonella perstans and Loa loa The complete microfilaria with its elegant and complex convolutions is that of M. perstans. It is smaller and thinner than the incomplete Loa loa microfilaria. The somatic nuclei of M. perstans are visible as far as the rounded caudal end of the microfilaria (Thick film stained with Giemsa). -
Filaria Zoogeography in Africa: Ecology, Competitive Exclusion, And
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Uniformed Services University of the Health U.S. Department of Defense Sciences 2014 Filaria zoogeography in Africa: ecology, competitive exclusion, and public health relevance David Molyneux Liverpool School of Tropical Medicine, [email protected] Edward Mitre The Uniformed Services University of Health Sciences Moses J. Bockarie Liverpool School of Tropical Medicine Louise A. Kelly-Hope Liverpool School of Tropical Medicine Follow this and additional works at: http://digitalcommons.unl.edu/usuhs Molyneux, David; Mitre, Edward; Bockarie, Moses J.; and Kelly-Hope, Louise A., "Filaria zoogeography in Africa: ecology, competitive exclusion, and public health relevance" (2014). Uniformed Services University of the Health Sciences. 138. http://digitalcommons.unl.edu/usuhs/138 This Article is brought to you for free and open access by the U.S. Department of Defense at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Uniformed Services University of the Health Sciences by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Opinion Filaria zoogeography in Africa: ecology, competitive exclusion, and public health relevance 1 2 1 1 David H. Molyneux , Edward Mitre , Moses J. Bockarie , and Louise A. Kelly-Hope 1 Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK 2 Department of Microbiology and Immunology, The Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA Six species of filariae infect humans in sub-Saharan a change in morphology’, precisely that experienced by Africa. We hypothesise that these nematodes are able parasites transmitted by vectors. -
Mansonellosis: Current Perspectives
Journal name: Research and Reports in Tropical Medicine Article Designation: REVIEW Year: 2018 Volume: 9 Research and Reports in Tropical Medicine Dovepress Running head verso: Ta-Tang et al Running head recto: Mansonellosis update open access to scientific and medical research DOI: http://dx.doi.org/10.2147/RRTM.S125750 Open Access Full Text Article REVIEW Mansonellosis: current perspectives Thuy-Huong Ta-Tang1 Abstract: Mansonellosis is a filarial disease caused by three species of filarial (nematode) James L Crainey2 parasites (Mansonella perstans, Mansonella streptocerca, and Mansonella ozzardi) that use Rory J Post3,4 humans as their main definitive hosts. These parasites are transmitted from person to person by Sergio LB Luz2 bloodsucking females from two families of flies (Diptera). Biting midges (Ceratopogonidae) José M Rubio1 transmit all three species of Mansonella, but blackflies (Simuliidae) are also known to play a role in the transmission of M. ozzardi in parts of Latin America. M. perstans and M. streptocerca are 1 Malaria and Emerging Parasitic endemic in western, eastern, and central Africa, and M. perstans is also present in the neotropical Diseases Laboratory, National Microbiology Center, Instituto de region from equatorial Brazil to the Caribbean coast. M. ozzardi has a patchy distribution in Latin Salud Carlos III, Majadahonda, Spain; America and the Caribbean. Mansonellosis infections are thought to have little pathogenicity and 2Laboratory of Infectious Disease Ecology in the Amazon, Oswaldo to be almost always asymptomatic, but occasionally causing itching, joint pains, enlarged lymph Cruz Foundation, Instituto Leônidas e glands, and vague abdominal symptoms. In Brazil, M. ozzardi infections are also associated with 3 Maria Deane, Manaus, Brazil; School corneal lesions. -
Imported Infections with Mansonella Perstans Nematodes, Italy
DISPATCHES Imported Infections with Mansonella perstans Nematodes, Italy In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate. For CME questions, see page 1624. Release date: August 15, 2017; Expiration date: August 15, 2018 Learning Objectives Upon completion of this activity, participants will be able to: • Identify the life cycle of Mansonella perstans. • Distinguish the most common country of origin among patients infected with Mansonella perstans in the current study. • Assess common symptoms of infection with Mansonella perstans. • Identify first-line treatment for Mansonella perstans in the current study. CME Editor Thomas J. Gryczan, MS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Thomas J. Gryczan, MS, has disclosed no relevant financial relationships. CME Author Charles P. Vega, MD, Health Sciences Clinical Professor, UC Irvine Department of Family Medicine; Associate Dean for Diversity and Inclusion, UC Irvine School of Medicine, Irvine, California, USA.